GSK technical analysis
GSK Technical Analysis
Analysis date
July 15, 2026
Market
NYSE (USD)
Daily cutoff
July 14, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
GSK Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- GSK
- Market
- NYSE
- Currency
- USD (US Dollar)
- Latest completed bar
- July 14, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 51.25 | July 14, 2026 | - | Verified |
| Finviz (independent) | 51.25 | July 14, 2026 (previous close) | 0.00% | Verified |
Bottom line
GSK Technical Analysis Summary
GSK presents a cautiously bearish technical picture across both daily and weekly timeframes. The stock closed at $51.25 on July 14, 2026, trading below both its SMA20 ($52.17) and SMA50 ($51.39), while remaining just above the SMA200 ($51.03). The RSI at 45.10 reflects neutral-bearish momentum with no oversold signal yet. The stock has pulled back 16.93% from its 52-week high of $61.69, pressured by the recent $10.6 billion Nuvalent acquisition announcement and broader pharma sector headwinds. Key support sits near the SMA200 at $51.00 and the 52-week low of $35.45. Resistance is at SMA50 ($51.39), SMA20 ($52.17), and the 20-day high near $53.50. A break below $51.00 would open the path toward lower support levels.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 14, 2026)
- Trend
- Bearish. Price at 51.25 is below SMA20 (52.17), SMA50 (51.39), and barely above SMA200 (51.03). The SMA20 is below SMA50, confirming a short-term downtrend. Price action shows lower highs since the June peak near 58.50.
- Momentum
- Neutral to bearish. RSI14 at 45.10 is in bearish territory, trending down from overbought levels earlier this year. MACD is negative with the MACD line below the signal line, reflecting ongoing selling pressure.
- Volatility
- Moderate. ATR14 at 1.11 (2.17% of price) suggests average daily movement of about $1.11. Recent price swings have widened following the Nuvalent deal announcement on June 9.
- Volume
- Slightly below average. Latest volume of 3,315,365 is 86.6% of the 20-period average (3,830,000), indicating reduced participation during the current pullback phase.
Assessment
The daily chart shows GSK in a well-defined downtrend since the June high. Price has broken below both the 20-day and 50-day moving averages, and the negative MACD confirms bearish momentum. The stock is testing the SMA200 at $51.03, a critical technical level. A breakdown below this support would likely accelerate selling toward the next support zone near $49-$50. The below-average volume during this decline is mixed, suggesting either a lack of aggressive selling or a lack of buying interest.
Weekly (July 10, 2026)
- Trend
- Bearish. Price at 51.25 is below SMA20 and SMA50 on the weekly chart. The stock has declined sharply from the 52-week high of 61.69, erasing most of the gains made in the first half of 2026.
- Momentum
- Bearish. Weekly RSI14 is estimated near 42-44, trending lower. The weekly MACD has crossed into negative territory, and the histogram is expanding downward, confirming intermediate-term bearish momentum.
- Volatility
- Elevated. Weekly ATR is approximately 2.80 (5.5% of price), reflecting above-average weekly ranges during the recent selloff.
- Volume
- Above average on down weeks. Volume spiked during the week of June 9 (Nuvalent deal), suggesting institutional distribution. Recent weeks show above-average volume on declining prices.
Assessment
The weekly chart paints a concerning picture for GSK. After reaching a 52-week high of $61.69 in early June, the stock has reversed sharply, losing nearly 17% in about five weeks. The weekly MACD has turned negative, and the stock is now testing long-term support levels. The 52-week position at approximately 60% leaves room for further downside. The weekly trend change from bullish to neutral-bearish is significant and suggests a potential intermediate-term trend reversal. Key support on the weekly chart is at $49.00 and the 52-week low of $35.45.
Key indicators
GSK Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 45.10 | 43.50 |
| MACD (12, 26, 9) | -0.45 / 0.12 / -0.57 | -0.89 / -0.21 / -0.68 |
| ATR (14) | 1.11 (2.17%) | 2.80 (5.46%) |
| Bollinger Bands (20, 2) | 48.80 - 54.20 | 47.50 - 59.00 |
| SMA (20) | 52.17 | 54.80 |
| SMA (50) | 51.39 | 52.40 |
| SMA (200) | 51.03 | 47.20 |
Price structure
GSK Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 51.25 | 51.25 |
| 1-Period Return | -1.99% | -3.88% |
| 5-Period Return | -6.22% | -8.15% |
| 20-Period Return | -9.12% | -13.05% |
| 60-Period Return | -0.73% | +1.71% |
| 252-Period Return | +33.85% | +33.85% |
| 52-Week Low | 35.45 | 35.45 |
| 52-Week High | 61.69 | 61.69 |
| 52-Week Position | 59.84% | 59.84% |
Key levels
GSK Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 53.50 | 59.50 |
| 20-Period Low | 49.80 | 49.00 |
| 60-Period High | 58.50 | 61.69 |
| 60-Period Low | 49.00 | 47.20 |
Scenarios
GSK Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price reclaims the SMA20 at $52.17 and then the SMA50 at $51.39 with above-average volume.
Invalidation
Price breaks below the SMA200 at $51.03 and stays below for multiple sessions.
What to watch
Daily RSI moving above 50; MACD crossing back above the signal line; positive volume divergence; catalyst from the new CEO strategy update expected later in July.
Range-Bound
Trigger
Price oscillates between SMA200 support near $51.00 and SMA50 resistance near $51.40-$52.20.
Invalidation
A decisive close either above $52.20 (bullish breakout) or below $50.80 (bearish breakdown).
What to watch
RSI staying between 40 and 50; volume remaining below average; price respecting the SMA200 support level on intraday dips.
Bearish
Trigger
Price breaks below the SMA200 support at $51.03 with conviction, confirmed by a daily close below $50.80.
Invalidation
Price reclaims $52.00 and holds above the SMA20.
What to watch
Sustained closes below SMA200; weekly MACD histogram becoming more negative; selling volume accelerating; further analyst downgrades following the Nuvalent deal concerns.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (500 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 10, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 10, 2026. Generated July 15, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.